1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends

Global Biosimilars Market

  • July 2017
  • 124 pages
  • Mordor Intelligence LLP
Report ID: 5023809


Table of Contents

Search Inside

The global biosimilar market was estimated to be USD XX million in 2016 and is expected to reach USD XX million by 2021, witnessing a CAGR of XX% during the forecast period.

Biosimilar is a biological product, which is almost an identical copy of the original and is expected to possess active properties, similar to what was previously licensed. Biosimilars can be made only when the patent for the original product expires. Currently, Europe holds the largest market share in the biosimilar market, followed by Asia-Pacific. The Asia-Pacific market is witnessing the highest CAGR, mainly due to the proper & consistent guidelines issued by the regulatory authority and high adoption rate. The low-cost of a biosimilar is the primary driving force of the Asia-Pacific market. In countries, such as the United States, this market is still in its nascent stage; however, with a growing approval rate, the American market is expected to expand during the forecast period.


Several blockbuster pharmaceuticals going off-patent in the next 5 to10 years is the primary driver for this market. Patent expiry of blockbuster drugs, such as Humira, Enbrel and Remicade, which have been among the top selling drugs, globally, present a significant opportunity for new players to enter this market. Patent expiry is not specific to geographical locations but is spread across the globe, including Europe and the United States. Biosimilar’s price is close to 70-80% of the original product, and hence, the low price margin is unable to attract a major share of the customers. Next-generation model, like getting into agreement with insurance companies for better reimbursement, is further driving the market. Additionally, as global biosimilar market is still in its early phase, entry is easier, and opportunity of growth is high.


Developing a biosimilar drug is not easy, and opening a manufacturing facility costs between USD 100-250 million. The expensive process, along with high complexity, is the major restraint for this market. Additionally, inconsistent guidelines issued by the regulatory body, within the country, and competition from biobetters are inhibiting the biosimilar market growth

Market Segmentation

The biosimilar market is segmented by product class and geography.

By product class, the global biosimilar market is further segmented as follows –

Monoclonal Antibodies (Adalimumab, Infliximab, Rituximab, Trastuzumab, Bevacizumab and others)
Recombinant Hormones (Insulin, Human Growth Hormone, Follicle Stimulating Hormone)
Recombinant Growth Factors (Granulocyte Colony Stimulating Factor, Erythropoietin and others)
Immunomodulators (Interferon Alfa, Interferon Beta and others)
Anti-Inflammatory Agents (TNF Inhibitors and others)

By geography, the market is segmented into –

North America
Asia Pacific
The Middle East & Africa
South America

Some of the key players in this market are –

Accord Healthcare
Bioxpress Therapeutics
Eli Lilly
Harvest Moon Pharmaceuticals
Teva Pharmaceuticals
Zydus Cadila Healthcare
Key Deliverables

Market analysis for the global biosimilar market, with region-specific assessments and competition analysis.
Market definition along with the identification of key drivers, restraints opportunities and challenges.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with company profiles of key players with the analysis of their current strategic interests and key financial information.
Identification and analysis of the macro and micro factors that affect the global biosimilar market.
Insights of the market in the regions that have the highest potential for growth and also identify the markets that are still untapped.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:


The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Oncology Biosimilars Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2025

  • $ 5795
  • Industry report
  • September 2017
  • by Transparency Market Research

Global Oncology Biosimilars Market: Overview This report on the oncology biosimilars market analyzes the current and future scenario of the global market. Increasing prevalence of cancer, innovation in ...

Japan Biosimilars – A start of Authorized Biosimilar Era? - Biosimilar/BioPharma CMO opportunities – JP Conglomerates – A definite role to play for Global Market!

  • $ 4000
  • Industry report
  • August 2017
  • by MP Advisors

Major JP Innovator vs. Early entrant Mid size Japanese companies- TA focus approach – A Win Win Game! In this report, we attempt to evaluate key upcoming opportunity for Japan BS market, its competitive ...


  • $ 3247
  • Industry report
  • August 2017
  • by Visiongain

And Other Rising Companies – a Market Report Assessing Developers and Producers of Competitor Biologics Report Details Who Are the Leaders in the Emerging Biosimilar Drugs Market? Visiongain’s New ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.